Bright-Field Dual-Color Chromogenic In Situ Hybridization for Diagnosing Echinoderm Microtubule-Associated Protein-Like 4-Anaplastic Lymphoma Kinase-Positive Lung Adenocarcinomas-Reference-Cited by-同舟云学术

Bright-Field Dual-Color Chromogenic In Situ Hybridization for Diagnosing Echinoderm Microtubule-Associated Protein-Like 4-Anaplastic Lymphoma Kinase-Positive Lung Adenocarcinomas

Published:2011-10 Issue:10 Volume:6 Page:1677-1686
ISSN:1556-0864
Container-title:Journal of Thoracic Oncology
language:en
Short-container-title:Journal of Thoracic Oncology

Author:

Yoshida Akihiko,Tsuta Koji,Nitta Hiroaki,Hatanaka Yutaka,Asamura Hisao,Sekine Ikuo,Grogan Thomas M.,Fukayama Masashi,Shibata Tatsuhiro,Furuta Koh,Kohno Takashi,Tsuda Hitoshi

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Oncology

Reference23 articles.

1. Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer;Soda;Nature,2007

2. Non-solid oncogenes in solid tumors: EML4-ALK fusion genes in lung cancer;Mano;Cancer Sci,2008

3. KIF5B-ALK, a novel fusion oncokinase identified by an immunohistochemistry-based diagnostic system for ALK-positive lung cancer;Takeuchi;Clin Cancer Res,2009

4. Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer;Kwak;N Engl J Med,2010

5. Unique clinicopathologic features characterize ALK-rearranged lung adenocarcinoma in the western population;Rodig;Clin Cancer Res,2009

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. European Society of Toxicologic Pathology (Pathology 2.0 Molecular Pathology Special Interest Group): Review of In Situ Hybridization Techniques for Drug Research and Development;Toxicologic Pathology;2023-04

2. 5′ ALK Amplification in Neuroblastoma: A Case Report;Case Reports in Oncology;2021-03-23

3. Attenuated isolated 3’ signal: A highly challenging therapy relevant ALK FISH pattern in NSCLC;Lung Cancer;2020-05

4. Pathology, Biomarkers, and Molecular Diagnostics;Abeloff's Clinical Oncology;2020

5. Optimization of trypsin treatment condition utilizing immunohistochemistry for chromogenic in situ hybridization;Pathology International;2019-09-19